Startup Valuation Hong Kong | Pre-IPO & Fundraising Valuation

Why founders and funds get an independent valuation

A negotiated round price is not the same as a valuation. Investors set a price; a valuation explains what the business is worth and why. Both matter, and they are used for different things.

Fundraising. An independent view gives founders a defensible reference point in negotiation, and gives investors comfort that the price is grounded in analysis rather than momentum.
Share-based payments. Issuing options or share awards requires an ordinary share value under HKFRS 2 — which is not the preferred share price paid in the round.
Fund reporting. Venture and private equity funds mark portfolio holdings each period, often quarterly, under HKFRS 13 and IPEV guidelines.
Pre-IPO restructuring. Listings surface historical share issuances, option grants and group reorganisations that need to be measured, sometimes several years after the event.
Internal transfers and secondaries. Founder or employee share sales need a value that will not be challenged later by the tax authority or a subsequent investor.

Methods that fit early-stage companies

Standard DCF assumes a forecast you can rely on. For a company with two years of history and a hockey stick, that assumption does not hold, so the method has to change.

Method	When it fits
Backsolve (calibration)	A recent arm's length priced round exists — infer total equity value consistent with what investors actually paid for the preferred shares
Option pricing model (OPM)	Allocating equity value across share classes with different liquidation preferences, participation and conversion rights
Probability-weighted expected return (PWERM)	Discrete exit scenarios — IPO, trade sale, liquidation — with probabilities and timing, common closer to a listing
Monte Carlo simulation	Complex structures where the waterfall depends on the path of value, or where anti-dilution ratchets bite at some outcomes and not others
Market approach	Revenue or user multiples from comparable listed companies or funding transactions, where genuinely comparable names exist
Milestone / risk-adjusted DCF	Biotech and deep tech, where value depends on discrete technical or regulatory events with estimable probabilities

Preferred shares are worth more than ordinary shares. If your last round priced Series A preferred at HK$10 a share, your ordinary shares are not worth HK$10. Liquidation preferences, participation rights and conversion terms mean the classes have different economics, and allocation through the waterfall is what establishes the ordinary share value. Companies that grant options at the preferred round price generally understate the position and have to correct it later — usually at audit or during IPO preparation.

What matters in the information you provide

For valuation purposes, a long business plan is not more useful than a short one. What actually carries weight is the team's track record, a clear articulation of the business model and why it wins, evidence of traction, a realistic expansion plan, and a specific budget for the funds being raised. Generic AI-generated plan text adds length without adding evidence, and it is transparent to anyone reading a lot of these.

The cap table matters as much as the forecast. We need the full structure — every class, its preference, participation, conversion and anti-dilution terms, plus the option pool and any convertible instruments outstanding. Term sheets and articles, not a summary spreadsheet.

Sector experience

Valtech's team has valued technology, biotech and life science, blockchain and digital asset companies, SaaS businesses, and university-led science and technology projects — including pre-revenue and pre-profit companies where the analysis rests on scenarios rather than earnings, and startups in Hong Kong Science Park programmes.

Common questions

We closed a round last month. Can you just use that price?

It is the right starting point, but not the answer on its own. A backsolve calibrates total equity value to what investors paid, which is a strong market-based input. The value then has to be allocated across share classes, because the preferred shares investors bought carry rights ordinary shares do not. That allocation is what produces an ordinary share value for option grants or financial reporting.

Can you value a pre-revenue company?

Yes, and it is routine. Without earnings, the analysis relies on the most recent priced round, comparable transactions, scenario or milestone analysis with probability weighting, or a risk-adjusted forecast. Biotech, deep tech and university spin-outs are frequently valued on a milestone basis, where value depends on discrete technical or regulatory events.

Do you provide 409A valuations for a Hong Kong company with US investors?

Yes. Where a Hong Kong or Cayman holding company has US taxpayers holding options, a 409A-style valuation may be needed to set exercise prices safely under US tax rules. The analytical work overlaps substantially with an HKFRS 2 valuation — the difference is the framework the report is written to and the safe harbour requirements it needs to meet.

How often do funds need portfolio valuations?

Most private capital funds mark quarterly, some semi-annually, depending on the LP agreement and reporting commitments. Once the framework is established for a portfolio, subsequent periods are quicker because the methodology, comparable sets and calibration are already in place and are being updated rather than rebuilt.

Related valuation services

This page summarises how Valtech approaches this engagement type in Hong Kong. It is general information, not valuation, accounting, tax or legal advice for any specific entity. Scope and methodology are agreed in an engagement letter before work begins.

Startup and pre-IPO valuation